Evidence map›Paper›PMID 36979376›Full record

ReviewBiomolecules2023

Industrial Production of Proteins with

Giovanni Davide Barone, Anita Emmerstorfer-Augustin, Antonino Biundo, Isabella Pisano, Paola Coccetti, Valeria Mapelli, Andrea Camattari

Full text readReview
In one paragraph

Review in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Systematic optimization ofEngineering microbiology · 2026
    Review
  3. Article
  4. Article
  5. International journal of molecular sciences · 2026
    Article
  6. Article
  7. Article
  8. Recombinant Protein Drugs: A 2025 Update.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Alterations in proteinFrontiers in molecular biosciences · 2026
    Article
  20. Engineering small peptide secretion inFrontiers in bioengineering and biotechnology · 2026
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Giovanni Davide BaroneInstitute of Molecular Biotechnology, Graz University of Technology, NAWI Graz, 8010 Graz, Austria.
Anita Emmerstorfer-AugustinInstitute of Molecular Biotechnology, Graz University of Technology, NAWI Graz, 8010 Graz, Austria.
Antonino BiundoDepartment of Biosciences, Biotechnology and Biopharmaceutics, University of Bari Aldo Moro, Via E. Orabona, 4, 70125 Bari, Italy.
Isabella PisanoDepartment of Biosciences, Biotechnology and Biopharmaceutics, University of Bari Aldo Moro, Via E. Orabona, 4, 70125 Bari, Italy.ORCID 0000-0003-0728-2226
Paola CoccettiDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milano, Italy.ORCID 0000-0001-5898-5883
Valeria MapelliDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milano, Italy.
Andrea CamattariGINKGO BIOWORKS, 27 Drydock Avenue, 8th Floor Boston, Boston, MA 02210, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the mid-1960s, methylotrophic yeast

Indexed as

PichiaSaccharomycetalesHumansRecombinant ProteinsYeastsRecombinant Proteinsapplied biotechnologybioreactor-based approachesbiotechnologyindustrial biotechnologyKomagataella phaffiimethylotrophic yeastPichia pastorisprotein production

Identifiers

PMID36979376
PMCPMC10046876

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read12
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.